PharmacocinétiqueModélisation de la réponse antirétrovirale en méta-trajectoires de taux de CD4 en situation d’immunodépression profonde
Références (60)
- et al.
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
Lancet
(2007) - et al.
Efavirenz versus indinavir chez les patients naïfs infectés par le VIH1 à Abidjan (Côte d’Ivoire)
Med Mal Infect
(2008) - et al.
Sex differences in HIV-1 viral load and progression to AIDS
Lancet
(1998) Rapport mondial sur l’épidémie du SIDA
(2009)- et al.
Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d’Épidémiologie Clinique du SIDA en Aquitaine
AIDS
(1998) - et al.
CD4 cell counts at the third month of HAART may predict clinical failure
AIDS
(1999) - et al.
Rates of disease progression by baseline cd4 cell count and viral load after initiating triple-drug therapy
JAMA
(2001) - et al.
Modelling changes in CD4-positive t-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections. The Aquitaine Cohort, 1996–1997
Am J Epidemiol
(2001) - et al.
Low versus high CD4 cell count as starting point for introduction of antiretroviral treatment in resource-poor settings: a scenario-based analysis
Antivir Ther
(2003) - et al.
Predicting AIDS-related events using CD4 percentage or CD4 absolute counts
AIDS Res Ther
(2006)
Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment
J Acquir Immune Defic Syndr
(2006)
Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitorbased antiretroviral therapy in a resource-limited setting
AIDS Res Ther
(2007)
Predictors of disease progression in HIV infection: a review
AIDS Res Ther
(2007)
CD4+ T-cell-guided structured treatment interruptions of antiretroviral therapy in HIV disease: projecting beyond clinical trials
Antivir Ther
(2010)
Multiple CD4 + cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy
AIDS Res Hum Retroviruses
(2001)
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen
J Infect Dis
(2002)
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
J Acquir Immune Defic Syndr
(2004)
Joint modelling of bivariate longitudinal data with informative dropout and left-censoring, with application to the evolution of CD4+ cell count and HIV RNA viral load in response to treatment of HIV infection
Stat Med
(2005)
Immunological markers evolution after long term supervised treatment interruption in chronically HIV-1 infected patients with CD4 count above 400 cells/mm3
AIDS
(2005)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to < 500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Clin Infect Dis
(2005)
Discordant immunological and virological responses to antiretroviral therapy
J Antimicrob Chemother
(2006)
Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d’Ivoire: impact of alternative methods of CD4 count modelling
Eur J Epidemiol
(2007)
Étude de la région de l’amas Virgo par taxonomie
Astron Astrophys
(1979)
Méta-apprentissage d’expériences : une nouvelle voie en data mining
(2005)
Nouvelle technique d’analyse et prédiction en urgence: les métatrajectoires [abstract 1045a]
(2005)
Meta-trajectories: a new approach of data mining
(2003)
Traitement antirétroviral de l’infection à VIH chez l’adulte et l’adolescent en situation de ressources limitées:vers un accès universel
(2008)
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir or efavirenz
AIDS
(2001)
The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Côte d’Ivoire’s drug access initiative
AIDS
(2003)
The evaluation of the HIV/AIDS drug access initiatives in Côte d’Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa
AIDS
(2003)
Cited by (1)
Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings
2012, Patient Preference and Adherence
Copyright © 2011 Société Française de Pharmacologie et de Thérapeutique. Publié par Elsevier Masson SAS. Published by Elsevier Masson SAS All rights reserved.